Advertisement

Topics

Endocrinology Corporate

02:06 EDT 24th October 2017 | BioPortfolio

Genexine, Inc.

Genexine, Inc., listed on KOSDAQ (095700) since 2009, is a leading biotherapeutics company focused on immuno-oncology and orphan disease. Genexine has robust pipelines in clinical and pre-clinical stages based on long-acting Fc fusion technology and therapeutic DNA technology. In the clinical stage, Genexine has GX-H9 (long-acting human growth hormone, hGH...

LMC Diabetes & Endocrinology

LMC is an industry leader, providing Phase I-IV clinical trial services in 13 sites with 35 Endocrinologists, across four Canadian provinces. LMC Research is part of the LMC group of multi-disciplinary regional Centres of Excellence aimed at providing complete care in Diabetes, Endocrinology and Metabolism. Specific areas of interest in research primarily ...

Viramal

Viramal is an emerging specialty pharmaceutical company focused on the development of therapeutics that improve the quality of women’s health. The Company’s well-recognized management team has pioneered market-leading products in fertility and female sexual health, having successfully developed and licensed Crinone®, Replens® and RepHresh®. ...

Crinetics Pharmaceuticals

Crinetics Pharmaceuticals discovers and develops novel therapeutics targeting peptide hormone receptors for the treatment of specialty endocrine disorders in neuroendocrinology, reproductive medicine, and women’s health. Its pioneering small molecule somatostatin agonist program for the treatment of acromegaly and neuroendocrine tumors aims to provide...

Manna Research and LMC Diabetes & Endocrinology

Plaintiffs' Executive Committee on the Testosterone Replacement Therapy MDL

Innocrin Pharmaceuticals, Inc.

Innocrin discovers and develops novel, best-in-class oral inhibitors of CYP17 lyase, a validated enzyme target for the treatment of castration-resistant prostate cancer. VT-464 and the entire CYP17 inhibitor patent estate are wholly owned by Innocrin. CYP17 lyase inhibitors may also have high commercial potential for the treatment of breast cancer as we...

Lipocine, Inc.

Lipocine Inc. is a specialty pharmaceutical company developing innovative products for use in men’s and women’s health using its proprietary drug delivery technologies. Lipocine’s lead product candidate, LPCN 1021, is Phase III ready and is targeted to treat symptoms of low testosterone for men in need of testosterone replacement therapy. Th...

Synergy Pharmaceuticals Inc.

Synergy Pharmaceuticals, Inc. is a biopharmaceutical company focused on the development of new drugs to treat patients with gastrointestinal (GI) diseases and disorders. Synergy’s lead drug, plecanatide, and next generation candidate, SP-333, are proprietary analogs of the natural human GI hormone, uroguanylin, and members of the new class of guanylate ...

TheAmerican Association of Clinical Endocrinologists (AACE)

The American Association of Clinical Endocrinologists (AACE) represents more than 6,500 endocrinologists in the United States and abroad. AACE is the largest association of clinical endocrinologists in the world. The majority of AACE members are certified in Endocrinology, Diabetes and Metabolism and concentrate on the treatment of patients with endocrine ...

The American Association of Clinical Endocrinologists (AACE)

The American Association of Clinical Endocrinologists (AACE) represents more than 6,500 endocrinologists in the United States and abroad. AACE is the largest association of clinical endocrinologists in the world. The majority of AACE members are certified in endocrinology, diabetes and metabolism and concentrate on the treatment of patients with endocrine ...

The American Association of Clinical Endocrinologists

The American Association of Clinical Endocrinologists (AACE) represents more than 6,500 endocrinologists in the United States and abroad. AACE is the largest association of clinical endocrinologists in the world. The majority of AACE members are certified in Endocrinology and Metabolism and concentrate on the treatment of patients with endocrine and metabo...

Atterocor, Inc.

Atterocor is a drug development company focused on novel therapies for adrenal cancer. The Company launched in 2012 with a Series A financing led by top-tier life sciences investors Frazier Healthcare and 5AM Ventures. Atterocor is based in Ann Arbor, Michigan.

Curaxis Pharmaceutical Corp

Curaxis is an emerging specialty pharmaceutical company with a hormone drug product candidate for the treatment of Alzheimer's disease and multiple cancers. Curaxis' therapeutic platform is based on the hypothesis that many diseases of aging may be caused by age-related changes in the function of the hypothalamic-pituitary-gonadal (HPG) axis. The HPG axis is a hormonal endocrine feedback loop that...

Sandoz Inc.

Sandoz, a Division of the Novartis group, is a global leader in the field of generic pharmaceuticals, offering a wide array of high-quality, affordable products that are no longer protected by patents. Sandoz has a portfolio of about 1000 compounds and sells its products in more than 130 countries. Key product groups include antibiotics, treatments for central nervous system disorders, gastroint...

The International Menopause Society (IMS)

World Menopause Day on October 18th was initiated by the IMS, in collaboration with the World Health Organization, as an opportunity to alert the world to the importance of the menopause and the impact that it has on the lives of so many women all around the world. In observation of the Day, the IMS and the member national societies of CAMS, the Council of Affiliated Menopause Societies, distr...

Novo Nordisk, Inc.

Novo Nordisk is a global healthcare company with more than 87 years of innovation and leadership in diabetes care. The company also has leading positions within hemophilia care, growth hormone therapy and hormone therapy for women. Novo Nordisk's business is driven by the Triple Bottom Line: a commitment to social responsibility to employees and customers, environmental soundness and economic succ...

Xention Discovery Ltd

Ion channels influence a multitude of physiological processes from the generation of electrical activity in nerves involved in sensory and motor functions in the brain, to the control of contractile activity in heart, skeletal, and smooth muscle, to nutrient uptake, hormone secretion, cell replication and development and immune cell function.The importance of ion channels in disease pathology is w...

The Center for Sleep & Wake Disorders

The Center for Sleep & Wake Disorders is a full service sleep center caring for patients with all disorders of sleep and wakefulness. Patients enjoy the advantages of an expertly trained staff, the latest diagnostic equipment, and personalized attention in a quiet and comfortable out-patient atmosphere.Our mission at The Center for Sleep & Wake Disorders is to provide high quality, compassionate m...

National Organization for Rare Disorders

Mission StatementThe National Organization for Rare Disorders (NORD), a 501(c)3 organization, is a unique federation of voluntary health organizations dedicated to helping people with rare "orphan" diseases and assisting the organizations that serve them. NORD is committed to the identification, treatment, and cure of rare disorders through programs of education, advocacy, research, and service. W...

Probiodrug AG

Probiodrug AG was established in 1997 as a spin off of the "Hans-Knöll-Institut für Wirkstoffforschung". Probiodrug is a wholly privately owned science driven drug development company, founded by Dr.'s. Hans-Ulrich Demuth and Konrad Glund, biochemists by education. The company is financed through venture capital and silent partnerships and successfully acquired R&D grants. The scientific advisor...

Inflabloc Pharmaceuticals, Inc.

Inflabloc Pharmaceuticals, Inc. is a privately-held pharmaceutical company located in Salt Lake City, Utah. The company is engaged in the research and development of pharmaceutical treatments for inflammatory disorders.Inflabloc's research is based on the discovery and elucidation of anti-inflammatory properties of dehydroepiandrosterone (DHEA), a steroid that is produced in the adrenal gland. The...

Pacific Sleep Medicine Services, Inc

Pacific Sleep Medicine Services offers individual consultations and diagnostic evaluations for patients suspected of sleep disorders. All of our physicians are board certified sleep specialists, dedicated to identifying and providing treatment recommendations for sleep disorders by working with patients and their referring physicians in treating sleep disorders.

Paradigm Therapeutics Ltd

Paradigm Therapeutics was founded in 1999 and has established world class target identification and validation capabilities based on gene knock out technology and in vivo pharmacology. The acquisition of Amedis Pharmaceuticals in January 2005 added key medicinal chemistry skills. The combined company has focused on the identification of novel, small molecule tractable targets with defined therapeu...

Motac

Motac Neuroscience provides highly-specialised services for the pharmaceutical and biotechnology industries to support the discovery and development of therapeutics for neurological and psychiatric disorders. Motac personnel have extensive expertise in neurodegenerative conditions, particularly Parkinson's disease and other movement disorders.Motac also has an intellectual property portfolio prote...

Quick Search
Advertisement
 

review and buy Endocrinology market research data and corporate reports here